type 2 diabetes

Novo Nordisk’s Victoza gets FDA okay for pediatric use
Novo Nordisk’s Victoza gets FDA okay for pediatric use
Pharmaforum
Novo Nordisk
Victoza
type 2 diabetes
pediatric
Flag link:
Lilly plans phase 2b NASH trial of dual GIP, GLP-1 agonist
Lilly plans phase 2b NASH trial of dual GIP, GLP-1 agonist
Fierce Biotech
Eli Lilly
NASH
tirzepatide
clinial trials
ADA
type 2 diabetes
Flag link:
Beyond glucose in type 2 diabetes: how Novo Nordisk is looking to address chronic kidney disease
Beyond glucose in type 2 diabetes: how Novo Nordisk is looking to address chronic kidney disease
Pharmaforum
Novo Nordisk
type 2 diabetes
diabetes
chronic kidney disease
Flag link:
Insulin Patch Earns Spot in American Diabetes Association Guidelines for Diabetes Care
Insulin Patch Earns Spot in American Diabetes Association Guidelines for Diabetes Care
Xtalks
diabetes
type 2 diabetes
insulin patch
ADA
Valeritas
V-Go
devices
Flag link:
Oramed spearheading human oral insulin trials in 37 US centers
Oramed spearheading human oral insulin trials in 37 US centers
CP Wire
Oramed
insulin
oral insulin
diabetes
type 2 diabetes
clinical trials
Flag link:
Oramed spearheading human oral insulin trials in 37 US centers
Oramed
insulin
type 2 diabetes
diabetes
clinical trials
oral insulin
Flag link:
FDA approves AstraZeneca's triple combination therapy for type 2 diabetes
FDA approves AstraZeneca's triple combination therapy for type 2 diabetes
Healio
AstraZeneca
type 2 diabetes
FDA
Qternmet XR
Flag link:
Novo seeks Victoza label expansion with fresh pediatric trial results
Novo seeks Victoza label expansion with fresh pediatric trial results
Biopharma Dive
Novo Nordisk
type 2 diabetes
pediatrics
Victoza
Flag link:
BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models
BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models
Fierce Biotech
Eli Lilly
Boehringer Ingelheim
Jardiance
type 2 diabetes
heart failure
Flag link:
Trial sets up 2020 filing for Poxel’s novel diabetes drug
Trial sets up 2020 filing for Poxel’s novel diabetes drug
Pharmaforum
Poxel
Japan
diabetes
type 2 diabetes
clinical trials
imeglimin
Flag link:
Intarcia licenses Numab's autoimmune therapy
Intarcia licenses Numab's autoimmune therapy
BioCentury
Intarcia
Numab
BD016
type 2 diabetes
Flag link:
AstraZeneca gets FDA expanded approval for Farxiga and Xigduo XR
AstraZeneca gets FDA expanded approval for Farxiga and Xigduo XR
Pharmaceutical Business Review
AstraZeneca
type 2 diabetes
Farxiga
Xigduo XR
FDA
Flag link:
Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride
Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride
Pharmaceutical Business Review
Boehringer Ingelheim
Eli Lilly
glimepiride
linagliptin
Tradjenta
type 2 diabetes
clinical trials
Flag link:
Merck bags global rights to NGM NASH drug, plans phase 2b trial
Merck bags global rights to NGM NASH drug, plans phase 2b trial
Fierce Biotech
Merck
NASH
NGM Biopharmaceuticals
type 2 diabetes
clinical trials
MK-3655
Flag link:
FDA Slaps Clinical Hold on Zafgen’s Lead Product Over Safety Concerns
FDA Slaps Clinical Hold on Zafgen’s Lead Product Over Safety Concerns
BioSpace
Zafgen
clinical trials
FDA
diabetes
ZGN-1061
type 2 diabetes
Flag link:
Novo Nordisk’s diabetes pill clears cardiac safety hurdle
Novo Nordisk’s diabetes pill clears cardiac safety hurdle
Pharmaforum
Novo Nordisk
semaglutides
type 2 diabetes
clinical trials
cardiovascular outcomes
Flag link:
Millions left behind as diabetes drives surge in insulin demand
Millions left behind as diabetes drives surge in insulin demand
Reuters
diabetes
type 2 diabetes
insulin
Flag link:
A startup for diabetes patients rolls out a new model: Insurers only pay if the service works
A startup for diabetes patients rolls out a new model: Insurers only pay if the service works
Stat
devices
digital coaching
type 2 diabetes
Virta Health
Flag link:
Questions Raised About Invokana Label Expansion For CV Risk Reduction
Questions Raised About Invokana Label Expansion For CV Risk Reduction
Forbes
Janssen
JNJ
Invokana
type 2 diabetes
Flag link:
Johnson & Johnson bags long-awaited cardiovascular nod for diabetes drug Invokana
Johnson & Johnson bags long-awaited cardiovascular nod for diabetes drug Invokana
Fierce Pharma
JNJ
Invokana
type 2 diabetes
Flag link:

Pages